Cargando…
Effects of intrapericardial administration after catheter drainage on malignant pericardial effusion in non‐small cell lung cancer: A real‐world study
BACKGROUND: Malignant pericardial effusion (MPE) is a serious complication of cancer that can be potentially deadly. It usually occurs in advanced or terminal stages of the disease, and as a result, patients with MPE often have a poor prognosis. There is a limited amount of research available that d...
Autores principales: | Wei, Jingwen, Shi, Zheng, Song, Zhengbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523995/ https://www.ncbi.nlm.nih.gov/pubmed/37533215 http://dx.doi.org/10.1002/cam4.6404 |
Ejemplares similares
-
Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer
por: Moriya, T, et al.
Publicado: (2000) -
Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion
por: Numico, Gianmauro, et al.
Publicado: (2016) -
Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
por: Imai, Hisao, et al.
Publicado: (2021) -
Voluminous Intrapericardial Lipoma Mimicking Pericardial Effusion
por: Prado de Morais, Fabíola, et al.
Publicado: (2020) -
A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
por: Kunitoh, H, et al.
Publicado: (2009)